We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
-12.08%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$19.6B
AUM Growth
-$4.7B
(-19%)
Cap. Flow
-$1.27B
Cap. Flow
% of AUM
-6.49%
Top 10 Holdings %
Top 10 Hldgs %
18.42%
Holding
1,935
New
296
Increased
592
Reduced
625
Closed
249
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$324M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$137M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Travelers Companies
TRV
|
+$109M |
| 5 |
Check Point Software Technologies
CHKP
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$286M |
| 2 |
UBS Group
UBS
|
+$189M |
| 3 |
Mettler-Toledo International
MTD
|
+$116M |
| 4 |
Cisco
CSCO
|
+$113M |
| 5 |
HCA Healthcare
HCA
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.93% |
| 2 | Healthcare | 17.38% |
| 3 | Consumer Staples | 12.07% |
| 4 | Financials | 9.42% |
| 5 | Materials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Smith-Midland
SMID
$146M
| $216K | ﹤0.01% |
15,396
-3,418
| -18% | -$54.9K |
|
1177
Douglas Emmett
DEI
$1.93B
| $214K | ﹤0.01% |
+9,557
| New | +$266K |
|
1178
Extra Space Storage
EXR
$31B
| $214K | ﹤0.01% |
1,256
-853
| -40% | -$158K |
|
|
NGM
1179
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $214K | ﹤0.01% |
16,716
+1,563
| +10% | +$21.6K |
|
|
RVI
1180
DELISTED
Retail Value Inc. Common Shares
RVI
| $214K | ﹤0.01% |
172,325
-5,000
| -3% | -$15K |
|
1181
Jerash Holdings
JRSH
$65.7M
| $213K | ﹤0.01% |
45,200
-1,099
| -2% | -$6.54K |
|
1182
BridgeBio Pharma
BBIO
$16.6B
| $212K | ﹤0.01% |
+23,445
| New | +$196K |
|
1183
NLI Holdings
NL
$308M
| $212K | ﹤0.01% |
+21,480
| New | +$173K |
|
1184
NetSol Technologies
NTWK
$50.5M
| $212K | ﹤0.01% |
66,421
| – | – |
|
1185
Xcel Energy
XEL
$48B
| $212K | ﹤0.01% |
2,999
-1,201
| -29% | -$87.4K |
|
1186
Precigen
PGEN
$2.51B
| $211K | ﹤0.01% |
+156,952
| New | +$233K |
|
1187
iShares MSCI Canada ETF
EWC
$6.48B
| $210K | ﹤0.01% |
6,237
-6,013
| -49% | -$223K |
|
1188
Iron Mountain
IRM
$36.2B
| $210K | ﹤0.01% |
4,314
+1,811
| +72% | +$95.3K |
|
|
OLP
1189
One Liberty Properties
OLP
$512M
| $209K | ﹤0.01% |
+8,029
| New | +$222K |
|
1190
Spyre Therapeutics
SYRE
$9.29B
| $208K | ﹤0.01% |
16,535
+10,559
| +177% | +$370K |
|
|
BDN
1191
Brandywine Realty Trust
BDN
$530M
| $207K | ﹤0.01% |
+21,455
| New | +$242K |
|
1192
Lennar Class B
LEN.B
$20.2B
| $204K | ﹤0.01% |
3,650
| – | – |
|
1193
Pentair
PNR
$10.7B
| $204K | ﹤0.01% |
4,473
-13,634
| -75% | -$682K |
|
1194
Champion Homes
SKY
$5.05B
| $204K | ﹤0.01% |
4,307
-4,770
| -53% | -$246K |
|
|
FONR
1195
DELISTED
Fonar
FONR
| $203K | ﹤0.01% |
13,335
-683
| -5% | -$11.5K |
|
1196
Live Nation Entertainment
LYV
$43B
| $203K | ﹤0.01% |
2,464
-11,140
| -82% | -$1.07M |
|
|
RJET
1197
Republic Airways Holdings
RJET
$946M
| $203K | ﹤0.01% |
+6,153
| New | +$289K |
|
1198
Taysha Gene Therapies
TSHA
$1.83B
| $199K | ﹤0.01% |
+53,447
| New | +$212K |
|
|
ALLG
1199
DELISTED
Allego N.V.
ALLG
| $198K | ﹤0.01% |
+38,861
| New | +$356K |
|
|
FISV
1200
Fiserv Inc
FISV
$27.8B
| $197K | ﹤0.01% |
2,216
| – | – |
|
Similar funds
Acadian Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Acadian Asset Management held 1,935 positions worth $19.6B, down 19% from $24.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Acadian Asset Management withdrew a net $1.27B in Q2 2022, closing 249 positions and reducing 625 holdings. Its most notable exit was UBS Group, an estimated $189M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Acadian Asset Management opened a new position in HF Sinclair worth $77.4M.
- Acadian Asset Management's largest Q2 2022 buy was HF Sinclair: 1,714,325 shares worth $77.4M.
- Acadian Asset Management added most to GSK in Q2 2022, an estimated $324M increase.
- Acadian Asset Management's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $286M.
- Acadian Asset Management fully exited UBS Group in Q2 2022, selling an estimated $189M.
- Acadian Asset Management's ten largest holdings make up 18% of its $19.6B portfolio in Q2 2022.
- Acadian Asset Management opened 296 new positions and closed 249 in Q2 2022.
- Acadian Asset Management's portfolio value fell 19% quarter-over-quarter to $19.6B.
Based on Acadian Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.